Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 28,647

Sort by:

Obstructive Sleep Apnea (Respiratory) - Drugs in Development, 2021

US$ 2,000.00

Obstructive Sleep Apnea (Respiratory) - Drugs in Development, 2021 SUMMARY Obstructive Sleep Apnea (Respiratory) - Drugs in Development, 2021 provides an overview of the Obstructive Sleep Apnea pipeli...

April 2021 55 pages

Ocular Inflammation (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Ocular Inflammation (Ophthalmology) - Drugs in Development, 2021 SUMMARY Ocular Inflammation (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Ocular Inflammation pipeline lands...

April 2021 85 pages

Ocular Melanoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Ocular Melanoma (Oncology) - Drugs in Development, 2021 SUMMARY Ocular Melanoma (Oncology) - Drugs in Development, 2021 provides an overview of the Ocular Melanoma pipeline landscape. The report provi...

April 2021 40 pages

Ocular Pain (Eye Pain) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Ocular Pain (Eye Pain) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Ocular Pain (Eye Pain) (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Ocular Pai...

April 2021 55 pages

Onchocerciasis (River Blindness) (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Onchocerciasis (River Blindness) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Onchocerciasis (River Blindness) (Infectious Disease) - Drugs in Development, 2021 provides an overview of th...

April 2021 35 pages

Open-Angle Glaucoma (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Open-Angle Glaucoma (Ophthalmology) - Drugs in Development, 2021 SUMMARY Open-Angle Glaucoma (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Open-Angle Glaucoma pipeline lands...

April 2021 85 pages

Opioid Induced Side Effects (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Opioid Induced Side Effects (Oncology) - Drugs in Development, 2021 SUMMARY Opioid Induced Side Effects (Oncology) - Drugs in Development, 2021 provides an overview of the Opioid Induced Side Effects...

April 2021 30 pages

Opioid Receptor (OPR) - Drugs in Development, 2021

US$ 3,000.00

Opioid Receptor (OPR) - Drugs in Development, 2021 SUMMARY Opioid Receptor (OPR) - Drugs in Development, 2021 provides in depth analysis on Opioid Receptor (OPR) targeted pipeline therapeutics. The re...

April 2021 40 pages

Opium Withdrawal Syndrome (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Opium Withdrawal Syndrome (Central Nervous System) - Drugs in Development, 2021 SUMMARY Opium Withdrawal Syndrome (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Opiu...

April 2021 35 pages

Optic Nerve Injury (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Optic Nerve Injury (Ophthalmology) - Drugs in Development, 2021 SUMMARY Optic Nerve Injury (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Optic Nerve Injury pipeline landscap...

April 2021 35 pages

Oral Cavity (Mouth) Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Oral Cavity (Mouth) Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Oral Cavity (Mouth) Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Oral Cavity (Mouth) Cancer pip...

April 2021 75 pages

Ornithine Carbamoyltransferase Mitochondrial (Ornithine Transcarbamylase or OTC or EC 2.1.3.3) - Drugs in Development, 2021

US$ 3,000.00

Ornithine Carbamoyltransferase Mitochondrial (Ornithine Transcarbamylase or OTC or EC 2.1.3.3) - Drugs in Development, 2021 SUMMARY Ornithine Carbamoyltransferase Mitochondrial (Ornithine Transcarbamy...

April 2021 35 pages

Ornithine Decarboxylase (ODC or ODC1 or EC 4.1.1.17) - Drugs in Development, 2021

US$ 3,000.00

Ornithine Decarboxylase (ODC or ODC1 or EC 4.1.1.17) - Drugs in Development, 2021 SUMMARY Ornithine Decarboxylase (ODC or ODC1 or EC 4.1.1.17) - Drugs in Development, 2021 provides in depth analysis o...

April 2021 35 pages

Oropharyngeal Candidiasis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Oropharyngeal Candidiasis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Oropharyngeal Candidiasis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Oropharyngea...

April 2021 30 pages

Osteopetrosis (Musculoskeletal Disorders) - Drugs in Development, 2021

US$ 2,000.00

Osteopetrosis (Musculoskeletal Disorders) - Drugs in Development, 2021 SUMMARY Osteopetrosis (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Osteopetrosis pipeline...

April 2021 30 pages

Otitis Externa (Ear Nose Throat Disorders) - Drugs in Development, 2021

US$ 2,000.00

Otitis Externa (Ear Nose Throat Disorders) - Drugs in Development, 2021 SUMMARY Otitis Externa (Ear Nose Throat Disorders) - Drugs in Development, 2021 provides an overview of the Otitis Externa pipel...

April 2021 30 pages

Oxysterols Receptor LXR Alpha (Liver X Receptor Alpha or Nuclear Receptor Subfamily 1 Group H Member 3 or LXRA or NR1H3) - Drugs in Development, 2021

US$ 3,000.00

Oxysterols Receptor LXR Alpha (Liver X Receptor Alpha or Nuclear Receptor Subfamily 1 Group H Member 3 or LXRA or NR1H3) - Drugs in Development, 2021 SUMMARY Oxysterols Receptor LXR Alpha (Liver X Rec...

April 2021 30 pages

Oxytocin Receptor (OTR or OXTR) - Drugs in Development, 2021

US$ 3,000.00

Oxytocin Receptor (OTR or OXTR) - Drugs in Development, 2021 SUMMARY Oxytocin Receptor (OTR or OXTR) - Drugs in Development, 2021 provides in depth analysis on Oxytocin Receptor (OTR or OXTR) targeted...

April 2021 60 pages

P27 (Negative Regulatory Factor or Nef) - Drugs in Development, 2021

US$ 3,000.00

P27 (Negative Regulatory Factor or Nef) - Drugs in Development, 2021 SUMMARY P27 (Negative Regulatory Factor or Nef) - Drugs in Development, 2021 provides in depth analysis on P27 (Negative Regulatory...

April 2021 40 pages

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Drugs in Development, 2021

US$ 3,000.00

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Drugs in Development, 2021 SUMMARY P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Drugs in Development, 2021 provides in depth analysis on P2X Purinoceptor 7...

April 2021 40 pages

p38 MAP Kinase (EC 2.7.11.24) - Drugs in Development, 2021

US$ 3,000.00

p38 MAP Kinase (EC 2.7.11.24) - Drugs in Development, 2021 SUMMARY p38 MAP Kinase (EC 2.7.11.24) - Drugs in Development, 2021 provides in depth analysis on p38 MAP Kinase (EC 2.7.11.24) targeted pipel...

April 2021 50 pages

Palmitoyl Protein Thioesterase 1 (Palmitoyl Protein Hydrolase 1 or CLN1 or PPT1 or EC 3.1.2.22) - Drugs in Development, 2021

US$ 3,000.00

Palmitoyl Protein Thioesterase 1 (Palmitoyl Protein Hydrolase 1 or CLN1 or PPT1 or EC 3.1.2.22) - Drugs in Development, 2021 SUMMARY Palmitoyl Protein Thioesterase 1 (Palmitoyl Protein Hydrolase 1 or...

April 2021 30 pages

Pancreatic Diseases (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Pancreatic Diseases (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Pancreatic Diseases (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Pancreatic Diseases pipeline...

April 2021 35 pages

Pancreatic Ductal Adenocarcinoma (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Pancreatic Ductal Adenocarcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Pancreatic Ductal Adenocarcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Pancreatic Ductal...

April 2021 325 pages

Pancreatic Ductal Carcinoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Pancreatic Ductal Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Pancreatic Ductal Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Pancreatic Ductal Carcinoma...

April 2021 30 pages

Pancreatic Endocrine Tumor (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Pancreatic Endocrine Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Pancreatic Endocrine Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Pancreatic Endocrine Tumor pip...

April 2021 30 pages

Pancreatic Islet Transplant Rejection (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Pancreatic Islet Transplant Rejection (Immunology) - Drugs in Development, 2021 SUMMARY Pancreatic Islet Transplant Rejection (Immunology) - Drugs in Development, 2021 provides an overview of the Panc...

April 2021 40 pages

Pandemic Influenza (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Pandemic Influenza (Infectious Disease) - Drugs in Development, 2021 SUMMARY Pandemic Influenza (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Pandemic Influenza pipelin...

April 2021 105 pages

Panic Disorders (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Panic Disorders (Central Nervous System) - Drugs in Development, 2021 SUMMARY Panic Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Panic Disorders pipeline...

April 2021 35 pages

Papillary Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Papillary Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Papillary Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Papillary Renal Cell C...

April 2021 35 pages

Papillary Thyroid Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Papillary Thyroid Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Papillary Thyroid Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Papillary Thyroid Cancer pipeline...

April 2021 70 pages

Papillary Tumor (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Papillary Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Papillary Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Papillary Tumor pipeline landscape. The report provi...

April 2021 30 pages

Paraganglioma (Glomus Jugulare Tumor) (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Paraganglioma (Glomus Jugulare Tumor) (Oncology) - Drugs in Development, 2021 SUMMARY Paraganglioma (Glomus Jugulare Tumor) (Oncology) - Drugs in Development, 2021 provides an overview of the Paragang...

April 2021 40 pages

Paralysis (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Paralysis (Central Nervous System) - Drugs in Development, 2021 SUMMARY Paralysis (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Paralysis pipeline landscape. The re...

April 2021 30 pages

Paramyxoviridae Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Paramyxoviridae Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Paramyxoviridae Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Paramyxovi...

April 2021 35 pages

Paranasal Sinus And Nasal Cavity Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Paranasal Sinus And Nasal Cavity Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Paranasal Sinus And Nasal Cavity Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Para...

April 2021 30 pages

Parathyroid Hormone/Parathyroid Hormone Related Peptide Receptor (PTH/PTHrP Type I Receptor or Parathyroid Hormone 1 Receptor or PTH1R) - Drugs in Development, 2021

US$ 3,000.00

Parathyroid Hormone/Parathyroid Hormone Related Peptide Receptor (PTH/PTHrP Type I Receptor or Parathyroid Hormone 1 Receptor or PTH1R) - Drugs in Development, 2021 SUMMARY Parathyroid Hormone/Parathy...

April 2021 35 pages

Partial Seizure (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Partial Seizure (Central Nervous System) - Drugs in Development, 2021 SUMMARY Partial Seizure (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Partial Seizure pipeline...

April 2021 40 pages

Pediatric Diffuse Intrinsic Pontine Glioma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Pediatric Diffuse Intrinsic Pontine Glioma (Oncology) - Drugs in Development, 2021 SUMMARY Pediatric Diffuse Intrinsic Pontine Glioma (Oncology) - Drugs in Development, 2021 provides an overview of th...

April 2021 95 pages

Pemphigus (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Pemphigus (Immunology) - Drugs in Development, 2021 SUMMARY Pemphigus (Immunology) - Drugs in Development, 2021 provides an overview of the Pemphigus pipeline landscape. The report provides comprehens...

April 2021 30 pages

Penicillin Binding Protein 2 (PBP2) - Drugs in Development, 2021

US$ 3,000.00

Penicillin Binding Protein 2 (PBP2) - Drugs in Development, 2021 SUMMARY Penicillin Binding Protein 2 (PBP2) - Drugs in Development, 2021 provides in depth analysis on Penicillin Binding Protein 2 (PB...

April 2021 35 pages

Penile Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Penile Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Penile Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Penile Cancer pipeline landscape. The report provides co...

April 2021 70 pages

Peptidyl Prolyl Cis Trans Isomerase (EC 5.2.1.8) - Drugs in Development, 2021

US$ 3,000.00

Peptidyl Prolyl Cis Trans Isomerase (EC 5.2.1.8) - Drugs in Development, 2021 SUMMARY Peptidyl Prolyl Cis Trans Isomerase (EC 5.2.1.8) - Drugs in Development, 2021 provides in depth analysis on Peptid...

April 2021 30 pages

Periodontal Disease (Mouth and Dental Disorders) - Drugs in Development, 2021

US$ 2,000.00

Periodontal Disease (Mouth and Dental Disorders) - Drugs in Development, 2021 SUMMARY Periodontal Disease (Mouth and Dental Disorders) - Drugs in Development, 2021 provides an overview of the Periodon...

April 2021 35 pages

Periostin (Osteoblast Specific Factor 2 or POSTN) - Drugs in Development, 2021

US$ 3,000.00

Periostin (Osteoblast Specific Factor 2 or POSTN) - Drugs in Development, 2021 SUMMARY Periostin (Osteoblast Specific Factor 2 or POSTN) - Drugs in Development, 2021 provides in depth analysis on Peri...

April 2021 35 pages

Peripheral Artery Occlusive Disease (PAOD) (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Peripheral Artery Occlusive Disease (PAOD) (Cardiovascular) - Drugs in Development, 2021 SUMMARY Peripheral Artery Occlusive Disease (PAOD) (Cardiovascular) - Drugs in Development, 2021 provides an ov...

April 2021 30 pages

Peripheral Myelin Protein 22 (Growth Arrest Specific Protein 3 or GAS3 or PMP22) - Drugs in Development, 2021

US$ 3,000.00

Peripheral Myelin Protein 22 (Growth Arrest Specific Protein 3 or GAS3 or PMP22) - Drugs in Development, 2021 SUMMARY Peripheral Myelin Protein 22 (Growth Arrest Specific Protein 3 or GAS3 or PMP22) -...

April 2021 30 pages

Peripheral Nerve Injury (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Peripheral Nerve Injury (Central Nervous System) - Drugs in Development, 2021 SUMMARY Peripheral Nerve Injury (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Peripher...

April 2021 40 pages

Peripheral Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Peripheral Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021 SUMMARY Peripheral Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021 provides an overview of the...

April 2021 50 pages

Peripheral Neuropathy (Sensory Neuropathy) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Peripheral Neuropathy (Sensory Neuropathy) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Peripheral Neuropathy (Sensory Neuropathy) (Central Nervous System) - Drugs in Development, 202...

April 2021 50 pages

Filters

Clear all